Compare $OSRH vs $SKYE | Chartloom

Compare

$OSRH vs $SKYE

OSR Holdings Inc · Skye Bioscience Inc

OSRH

OSR Holdings Inc

SKYE

Skye Bioscience Inc

Compare $OSRH vs $SKYE

Comparing OSR Holdings Inc and Skye Bioscience Inc

OSRHOSR Holdings Inc

SKYESkye Bioscience Inc

OSRHOSR Holdings Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-4.6%

YTD performance

-64.4%

52W performance

-65.3%

FCF yield

-100.0%

SKYESkye Bioscience Inc

Market cap

$59M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.9%

52W performance

-87.7%

FCF yield

-65.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OSRH

SKYE

Detailed metrics comparison

OSRH

OSR Holdings Inc

SKYE

Skye Bioscience Inc

Market Cap

OSRH$7M

SKYE$59M

Enterprise Value

OSRH$11M

SKYE$51M

Price

OSRH$0.21

SKYE$1.69

P/E Ratio

OSRHN/A

SKYEN/A

P/S Ratio

OSRH4.08x

SKYE26.57x

EV/Sales

OSRH6.25x

SKYE0.00x

EV/EBITDA

OSRH0.00x

SKYE0.00x

P/B Ratio

OSRH0.07x

SKYE0.83x

P/FCF Ratio

OSRHN/A

SKYEN/A

EV/FCF

OSRH-1.53x

SKYE-1.31x

PEG Ratio

OSRHN/A

SKYEN/A

Forward P/E (NTM)

OSRHN/A

SKYEN/A

Forward P/S (NTM)

OSRHN/A

SKYEN/A

Revenue (TTM)

OSRH$2M

SKYE$0

Revenue Growth (YoY)

OSRH-4.6%

SKYEN/A

Forward Rev Growth

OSRH0.0%

SKYE307.4%

Gross Margin (TTM)

OSRH35.3%

SKYE39.3%

Operating Margin (TTM)

OSRH0.0%

SKYE0.0%

EBITDA Margin (TTM)

OSRH-410.1%

SKYE0.0%

Net Margin (TTM)

OSRH-593.2%

SKYE0.0%

FCF Margin (TTM)

OSRH-407.9%

SKYEN/A

Net Income (TTM)

OSRH$-11M

SKYE$-50M

FCF (TTM)

OSRH$-7M

SKYE$-39M

EPS (TTM)

OSRH-$0.25

SKYE-$10.18

ROE (TTM)

OSRH-1167.0%

SKYE-21727.0%

ROA (TTM)

OSRH-624.0%

SKYE-20179.0%

ROIC (TTM)

OSRH-1110.0%

SKYE-21675.0%

Cash

OSRH$1M

SKYE$9M

Debt

OSRH$5M

SKYE$143K

Net Cash/Debt

OSRH$-4M

SKYE$8M

Current Ratio (TTM)

OSRH0.18x

SKYE0.95x

Quick Ratio (TTM)

OSRH0.14x

SKYE0.91x

Debt/Equity (TTM)

OSRH0.05x

SKYE0.03x

Debt/Assets (TTM)

OSRH0.0%

SKYE0.0%

Interest Coverage (TTM)

OSRHN/A

SKYEN/A

Net Debt/EBITDA (TTM)

OSRH0.00x

SKYE0.00x

Beta

OSRH0.51

SKYE3.13

52W Performance

OSRH-65.3%

SKYE-87.7%

YTD Performance

OSRH-64.4%

SKYE-75.9%

% from 52W High

OSRH-76.9%

SKYE-88.0%

% from 52W Low

OSRH180.0%

SKYE12.7%

Asset Turnover (TTM)

OSRH0.01x

SKYE1.93x

FCF Yield (TTM)

OSRH-100.0%

SKYE-65.4%

Earnings Yield (TTM)

OSRH-145.5%

SKYE-85.0%

Dividend Yield (TTM)

OSRHN/A

SKYEN/A

Rule of 40

OSRH-412.5

SKYE0.0

EV/GP/RG

OSRHN/A

SKYEN/A

Ticker research

View OSRH research View SKYE research

Metric	OSRH OSR Holdings Inc	SKYE Skye Bioscience Inc
Market & Valuation
Market Cap	$7M	$59M
Enterprise Value	$11M	$51M
Price	$0.21	$1.69
P/E Ratio	N/A	N/A
P/S Ratio	4.08x	26.57x
EV/Sales	6.25x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.07x	0.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-1.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-4.6%	N/A
Forward Rev Growth	0.0%	307.4%
Profitability
Gross Margin (TTM)	35.3%	39.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.1%	0.0%
Net Margin (TTM)	-593.2%	0.0%
FCF Margin (TTM)	-407.9%	N/A
Net Income (TTM)	$-11M	$-50M
FCF (TTM)	$-7M	$-39M
EPS (TTM)	-$0.25	-$10.18
ROE (TTM)	-1167.0%	-21727.0%
ROA (TTM)	-624.0%	-20179.0%
ROIC (TTM)	-1110.0%	-21675.0%
Financial Health
Cash	$1M	$9M
Debt	$5M	$143K
Net Cash/Debt	$-4M	$8M
Current Ratio (TTM)	0.18x	0.95x
Quick Ratio (TTM)	0.14x	0.91x
Debt/Equity (TTM)	0.05x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.51	3.13
52W Performance	-65.3%	-87.7%
YTD Performance	-64.4%	-75.9%
% from 52W High	-76.9%	-88.0%
% from 52W Low	180.0%	12.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	1.93x
FCF Yield (TTM)	-100.0%	-65.4%
Earnings Yield (TTM)	-145.5%	-85.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-412.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OSRH research	View SKYE research

Valuation

P/S Ratio

OSRH

4.08x

SKYE

26.57x

EV/FCF

OSRH

-1.53x

SKYE

-1.31x

Growth & revenue

Revenue Growth TTM

OSRH

-4.6%

Forward Revenue Growth

SKYE

307.4%

OSRH

0.0%

Profitability & performance

Gross Margin

SKYE

39.3%

OSRH

35.3%

ROE

OSRH

-1167.0%

SKYE

-21727.0%

FCF Yield %

SKYE

-65.4%

OSRH

-100.0%

52-Week Performance

OSRH

-65.3%

SKYE

-87.7%

Detailed metrics comparison

OSRH

OSR Holdings Inc

SKYE

Skye Bioscience Inc

Market Cap

OSRH$7M

SKYE$59M

Enterprise Value

OSRH$11M

SKYE$51M

Price

OSRH$0.21

SKYE$1.69

P/E Ratio

OSRHN/A

SKYEN/A

P/S Ratio

OSRH4.08x

SKYE26.57x

EV/Sales

OSRH6.25x

SKYE0.00x

EV/EBITDA

OSRH0.00x

SKYE0.00x

P/B Ratio

OSRH0.07x

SKYE0.83x

P/FCF Ratio

OSRHN/A

SKYEN/A

EV/FCF

OSRH-1.53x

SKYE-1.31x

PEG Ratio

OSRHN/A

SKYEN/A

Forward P/E (NTM)

OSRHN/A

SKYEN/A

Forward P/S (NTM)

OSRHN/A

SKYEN/A

Revenue (TTM)

OSRH$2M

SKYE$0

Revenue Growth (YoY)

OSRH-4.6%

SKYEN/A

Forward Rev Growth

OSRH0.0%

SKYE307.4%

Gross Margin (TTM)

OSRH35.3%

SKYE39.3%

Operating Margin (TTM)

OSRH0.0%

SKYE0.0%

EBITDA Margin (TTM)

OSRH-410.1%

SKYE0.0%

Net Margin (TTM)

OSRH-593.2%

SKYE0.0%

FCF Margin (TTM)

OSRH-407.9%

SKYEN/A

Net Income (TTM)

OSRH$-11M

SKYE$-50M

FCF (TTM)

OSRH$-7M

SKYE$-39M

EPS (TTM)

OSRH-$0.25

SKYE-$10.18

ROE (TTM)

OSRH-1167.0%

SKYE-21727.0%

ROA (TTM)

OSRH-624.0%

SKYE-20179.0%

ROIC (TTM)

OSRH-1110.0%

SKYE-21675.0%

Cash

OSRH$1M

SKYE$9M

Debt

OSRH$5M

SKYE$143K

Net Cash/Debt

OSRH$-4M

SKYE$8M

Current Ratio (TTM)

OSRH0.18x

SKYE0.95x

Quick Ratio (TTM)

OSRH0.14x

SKYE0.91x

Debt/Equity (TTM)

OSRH0.05x

SKYE0.03x

Debt/Assets (TTM)

OSRH0.0%

SKYE0.0%

Interest Coverage (TTM)

OSRHN/A

SKYEN/A

Net Debt/EBITDA (TTM)

OSRH0.00x

SKYE0.00x

Beta

OSRH0.51

SKYE3.13

52W Performance

OSRH-65.3%

SKYE-87.7%

YTD Performance

OSRH-64.4%

SKYE-75.9%

% from 52W High

OSRH-76.9%

SKYE-88.0%

% from 52W Low

OSRH180.0%

SKYE12.7%

Asset Turnover (TTM)

OSRH0.01x

SKYE1.93x

FCF Yield (TTM)

OSRH-100.0%

SKYE-65.4%

Earnings Yield (TTM)

OSRH-145.5%

SKYE-85.0%

Dividend Yield (TTM)

OSRHN/A

SKYEN/A

Rule of 40

OSRH-412.5

SKYE0.0

EV/GP/RG

OSRHN/A

SKYEN/A

Ticker research

View OSRH research View SKYE research

Metric	OSRH OSR Holdings Inc	SKYE Skye Bioscience Inc
Market & Valuation
Market Cap	$7M	$59M
Enterprise Value	$11M	$51M
Price	$0.21	$1.69
P/E Ratio	N/A	N/A
P/S Ratio	4.08x	26.57x
EV/Sales	6.25x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.07x	0.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-1.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-4.6%	N/A
Forward Rev Growth	0.0%	307.4%
Profitability
Gross Margin (TTM)	35.3%	39.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.1%	0.0%
Net Margin (TTM)	-593.2%	0.0%
FCF Margin (TTM)	-407.9%	N/A
Net Income (TTM)	$-11M	$-50M
FCF (TTM)	$-7M	$-39M
EPS (TTM)	-$0.25	-$10.18
ROE (TTM)	-1167.0%	-21727.0%
ROA (TTM)	-624.0%	-20179.0%
ROIC (TTM)	-1110.0%	-21675.0%
Financial Health
Cash	$1M	$9M
Debt	$5M	$143K
Net Cash/Debt	$-4M	$8M
Current Ratio (TTM)	0.18x	0.95x
Quick Ratio (TTM)	0.14x	0.91x
Debt/Equity (TTM)	0.05x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.51	3.13
52W Performance	-65.3%	-87.7%
YTD Performance	-64.4%	-75.9%
% from 52W High	-76.9%	-88.0%
% from 52W Low	180.0%	12.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	1.93x
FCF Yield (TTM)	-100.0%	-65.4%
Earnings Yield (TTM)	-145.5%	-85.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-412.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OSRH research	View SKYE research